Biotechnology has applications in four major industrial areas, including health care (medical), crop production and agriculture, non-food (industrial) uses of crops and other products (e.g.,
biodegradable plastics,
vegetable oil,
biofuels), and
environmental uses. For example, one application of biotechnology is the directed use of
microorganisms for the manufacture of organic products (examples include
beer and
milk products). Another example is using naturally present
bacteria by the
mining industry in
bioleaching. Biotechnology is also used to recycle, treat waste, clean up sites contaminated by industrial activities (
bioremediation), and also to produce
biological weapons. A series of derived terms have been coined to identify several branches of biotechnology, for example: •
Bioinformatics (or "gold biotechnology") is an interdisciplinary field that addresses biological problems using computational techniques, and makes the rapid organization as well as analysis of biological data possible. The field may also be referred to as
computational biology, and can be defined as, "conceptualizing biology in terms of molecules and then applying informatics techniques to understand and organize the information associated with these molecules, on a large scale". Bioinformatics plays a key role in various areas, such as
functional genomics,
structural genomics, and
proteomics, and forms a key component in the biotechnology and pharmaceutical sector. • Blue biotechnology is based on the exploitation of sea resources to create products and industrial applications. • Green biotechnology is biotechnology applied to agricultural processes. An example would be the selection and domestication of plants via
micropropagation. Another example is the designing of
transgenic plants to grow under specific environments in the presence (or absence) of chemicals. One hope is that green biotechnology might produce more environmentally friendly solutions than traditional
industrial agriculture. An example of this is the engineering of a plant to express a
pesticide, thereby ending the need of external application of pesticides. An example of this would be
Bt corn. Whether or not green biotechnology products such as this are ultimately more environmentally friendly is a topic of considerable debate. It is commonly considered as the next phase of green revolution, which can be seen as a platform to eradicate world hunger by using technologies which enable the production of more fertile and resistant, towards
biotic and
abiotic stress, plants and ensures application of environmentally friendly fertilizers and the use of biopesticides, it is mainly focused on the development of agriculture. • Yellow biotechnology refers to the use of biotechnology in food production (
food industry), for example in making wine (
winemaking), cheese (
cheesemaking), and beer (
brewing) by
fermentation. • Gray biotechnology is dedicated to environmental applications, and focused on the maintenance of
biodiversity and the remotion of pollutants. • Dark biotechnology is the color associated with
bioterrorism or
biological weapons and biowarfare which uses microorganisms, and toxins to cause diseases and death in humans, livestock and crops. chip – some can do as many as a million blood tests at once.
Pharmacogenomics (a combination of
pharmacology and
genomics) is the technology that analyses how genetic makeup affects an individual's response to drugs. Researchers in the field investigate the influence of
genetic variation on drug responses in patients by correlating
gene expression or
single-nucleotide polymorphisms with a drug's
efficacy or
toxicity. The purpose of pharmacogenomics is to develop rational means to optimize drug therapy, with respect to the patients'
genotype, to ensure maximum efficacy with minimal
adverse effects. Such approaches promise the advent of "
personalized medicine"; in which drugs and drug combinations are optimized for each individual's unique genetic makeup. , the
zinc ions holding it together, and the
histidine residues involved in zinc binding Biotechnology has contributed to the discovery and manufacturing of traditional
small molecule pharmaceutical drugs as well as drugs that are the product of biotechnology –
biopharmaceutics. Modern biotechnology can be used to manufacture existing medicines relatively easily and cheaply. The first genetically engineered products were medicines designed to treat human diseases. To cite one example, in 1978
Genentech developed synthetic humanized
insulin by joining its gene with a
plasmid vector inserted into the bacterium
Escherichia coli. Insulin, widely used for the treatment of diabetes, was previously extracted from the pancreas of
abattoir animals (cattle or pigs). The genetically engineered bacteria are able to produce large quantities of synthetic human insulin at relatively low cost. Biotechnology has also enabled emerging therapeutics like
gene therapy. The application of biotechnology to basic science (for example through the
Human Genome Project) has also dramatically improved our understanding of
biology and as our scientific knowledge of normal and disease biology has increased, our ability to develop new medicines to treat previously untreatable diseases has increased as well. Most of the time, testing is used to find changes that are associated with inherited disorders. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person's chance of developing or passing on a
genetic disorder. As of 2011 several hundred genetic tests were in use. Since genetic testing may open up ethical or psychological problems, genetic testing is often accompanied by
genetic counseling.
Agriculture Genetically modified crops ("GM crops", or "biotech crops") are plants used in
agriculture, the
DNA of which has been modified with
genetic engineering techniques. In most cases, the main aim is to introduce a new
trait that does not occur naturally in the species. Biotechnology firms can contribute to future food security by improving the nutrition and viability of
urban agriculture. Furthermore, the protection of intellectual property rights encourages private sector investment in agrobiotechnology. Examples in food crops include resistance to certain pests, diseases, stressful environmental conditions, resistance to chemical treatments (e.g. resistance to a
herbicide), reduction of spoilage, or improving the nutrient profile of the crop. Examples in non-food crops include production of
pharmaceutical agents,
biofuels, and other industrially useful goods, as well as for
bioremediation. Farmers have widely adopted GM technology. Between 1996 and 2011, the total surface area of land cultivated with GM crops had increased by a factor of 94, from . As of 2011, 11 different transgenic crops were grown commercially on in 29 countries such as the US,
Brazil,
Argentina,
India, Canada, China, Paraguay, Pakistan, South Africa, Uruguay, Bolivia, Australia, Philippines, Myanmar, Burkina Faso, Mexico, and Spain. Commercial sale of genetically modified foods began in 1994, when
Calgene first marketed its
Flavr Savr delayed ripening tomato. To date most genetic modification of foods have primarily focused on
cash crops in high demand by farmers such as
soybean,
corn,
canola, and
cotton seed oil. These have been engineered for resistance to pathogens and herbicides and better nutrient profiles. GM livestock have also been experimentally developed; in November 2013 none were available on the market, but in 2015 the FDA approved the first GM salmon for commercial production and consumption. There is a
scientific consensus Insect-resistant crops have proven to lower pesticide usage, therefore reducing the environmental impact of pesticides as a whole. However, opponents have objected to GM crops per se on several grounds, including environmental concerns, whether food produced from GM crops is safe, whether GM crops are needed to address the world's food needs, and economic concerns raised by the fact these organisms are subject to intellectual property law. Biotechnology has several applications in the realm of food security. Crops like
Golden rice are engineered to have higher nutritional content, and there is potential for food products with longer shelf lives. Though not a form of agricultural biotechnology, vaccines can help prevent diseases found in animal agriculture. Additionally, agricultural biotechnology can expedite breeding processes in order to yield faster results and provide greater quantities of food. Transgenic
biofortification in
cereals has been considered as a promising method to combat malnutrition in India and other countries.
Industrial Industrial biotechnology (known mainly in Europe as white biotechnology) is the application of biotechnology for industrial purposes, including
industrial fermentation. It includes the practice of using
cells such as
microorganisms, or components of cells like
enzymes, to generate
industrially useful products in sectors such as chemicals, food and feed, detergents, paper and pulp, textiles and
biofuels. In the current decades, significant progress has been done in creating
genetically modified organisms (GMOs) that enhance the diversity of applications and economical viability of industrial biotechnology. By using renewable raw materials to produce a variety of chemicals and fuels, industrial biotechnology is actively advancing towards lowering greenhouse gas emissions and moving away from a petrochemical-based economy.
Synthetic biology is considered one of the essential cornerstones in industrial biotechnology due to its financial and sustainable contribution to the manufacturing sector. Jointly biotechnology and synthetic biology play a crucial role in generating cost-effective products with
nature-friendly features by using bio-based production instead of fossil-based. Synthetic biology can be used to engineer
model microorganisms, such as
Escherichia coli, by
genome editing tools to enhance their ability to produce bio-based products, such as
bioproduction of medicines and
biofuels. For instance,
E. coli and
Saccharomyces cerevisiae in a consortium could be used as industrial microbes to produce precursors of the
chemotherapeutic agent paclitaxel by applying the
metabolic engineering in a co-culture approach to exploit the benefits from the two microbes. Another example of synthetic biology applications in industrial biotechnology is the re-engineering of the
metabolic pathways of
E. coli by
CRISPR and
CRISPRi systems toward the production of a chemical known as
1,4-butanediol, which is used in fiber manufacturing. In order to produce 1,4-butanediol, the authors alter the metabolic regulation of the
Escherichia coli by CRISPR to induce
point mutation in the
gltA gene,
knockout of the
sad gene, and
knock-in six genes (
cat1,
sucD,
4hbd,
cat2,
bld, and
bdh). Whereas CRISPRi system used to
knockdown the three competing genes (
gabD,
ybgC, and
tesB) that affect the biosynthesis pathway of 1,4-butanediol. Consequently, the yield of 1,4-butanediol significantly increased from 0.9 to 1.8 g/L.
Environmental Environmental biotechnology includes various disciplines that play an essential role in reducing environmental waste and providing
environmentally safe processes, such as
biofiltration and
biodegradation. The environment can be affected by biotechnologies, both positively and adversely. Vallero and others have argued that the difference between beneficial biotechnology (e.g.,
bioremediation is to clean up an oil spill or hazard chemical leak) versus the adverse effects stemming from biotechnological enterprises (e.g., flow of genetic material from transgenic organisms into wild strains) can be seen as applications and implications, respectively. Cleaning up environmental wastes is an example of an application of
environmental biotechnology; whereas
loss of biodiversity or loss of containment of a harmful microbe are examples of environmental implications of biotechnology. Many cities have installed
CityTrees, which use biotechnology to filter pollutants from urban atmospheres.
Regulation The regulation of genetic engineering concerns approaches taken by governments to assess and manage the
risks associated with the use of
genetic engineering technology, and the development and release of genetically modified organisms (GMO), including
genetically modified crops and
genetically modified fish. There are differences in the regulation of GMOs between countries, with some of the most marked differences occurring between the US and Europe. Regulation varies in a given country depending on the intended use of the products of the genetic engineering. For example, a crop not intended for food use is generally not reviewed by authorities responsible for food safety. The European Union differentiates between approval for cultivation within the EU and approval for import and processing. While only a few GMOs have been approved for cultivation in the EU a number of GMOs have been approved for import and processing. The cultivation of GMOs has triggered a debate about the coexistence of GM and non-GM crops. Depending on the coexistence regulations, incentives for the cultivation of GM crops differ.
Database for the GMOs used in the EU The
EUginius (European GMO Initiative for a Unified Database System) database is intended to help companies, interested private users and competent authorities to find precise information on the presence, detection and identification of GMOs used in the
European Union. The information is provided in English. ==Learning==